LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance

被引:80
作者
Barancik, Miroslav
Bohacova, Vierka
Sedlak, Jan
Sulova, Zdenka
Breier, Albert
机构
[1] Slovak Acad Sci, Heart Res Inst, Bratislava 84005 45, Slovakia
[2] Slovak Acad Sci, Inst Mol Physiol & Genet, Bratislava 83334, Slovakia
[3] Slovak Acad Sci, Inst Canc Res, Bratislava 83391, Slovakia
关键词
mouse leukaemia cells L1210; multidrug resistance; P-glycoprotein; vincristine; Akt kinase; protein kinase inhibitors; LY 294,002; protein phosphorylation;
D O I
10.1016/j.ejps.2006.08.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The transmembrane transport pump P-glycoprotein (P-gp) causes the efflux of chemotherapeutic agents from cells and is an important system that secures multidrug resistance (MDR) of neoplastic cells. in the present study drug sensitive L1210 and multidrug resistant L1210/VCR mouse leukemic cell lines were used as an experimental model. We found that LY 294,002, a specific inhibitor of PI3K/Akt kinase pathway, reduced the degree of vincristine resistance in L121/VCR cells significantly and in a concentration-dependent manner. This was accompanied by decrease in IC50 value to vincristine from 3.195 +/- 0.447 to 1.898 +/- 0.676 mu mol/l for 2 mu mol/l, to 0.947 +/- 0.419 mu mol/l for 4 mu mol/l, and to 0.478 +/- 0.202 mu mol/l for 8 mu mol/l LY294,002. The IC50 value of sensitive cells for vincristine was about 0.010 mu mol/l. FACS analysis of the proportion of cells in apoptosis or necrosis by annexin-V apoptosis kit showed the following: (i) vincristine-induced apoptosis in resistant cell to a much lower extent than in sensitive cells; (ii) LY294,002 alone did not induce apoptosis or necrosis in both sensitive and resistant cells; (iii) LY294,002 applied together with vincristine significantly increased the number of apoptotic cells. Transport activity of P-gp in resistant cells was monitored using calcein/AM as substrate and was depressed by LY294,002 in a concentration dependent manner. Significant differences in calcein retention were not observed when cells were preincubated with LY294,002 at different times from 0.5 to 24h. Sensitive and resistant cells contain similar amounts of uncleaved (i.e., unactivated) caspase-3 but in latter cells the activation of caspase-3 by proteolytic cleavage was decreased. The reversal of vincristine resistance by LY294,002 was associated with marked activation of caspase-3. Western blot analysis revealed that the development of MDR phenotype in L1210/VCR cells was also associated with increased level of Bcl-2 protein. All the above findings point to the possible involvement of PI3K/Akt kinase pathway in modulation of P-gp mediated multidrug resistance in L1210/VCR mouse leukemic cell line. MDR reversal effect of LY294,002 is accompanied with this compound's influence on vincristine-induced apoptosis. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:426 / 434
页数:9
相关论文
共 25 条
[1]   The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1 [J].
Abdul-Ghani, R ;
Serra, V ;
Györffy, B ;
Jürchott, K ;
Solf, A ;
Dietel, M ;
Schäfer, R .
ONCOGENE, 2006, 25 (12) :1743-1752
[2]   SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance [J].
Barancík, M ;
Bohácová, V ;
Kvackajová, J ;
Hudecová, S ;
Krizanová, O ;
Breier, A .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (01) :29-36
[3]  
Bohácová V, 2000, PHYSIOL RES, V49, P447
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   P-glycoprotein -: Implications of metabolism of neoplastic cells and cancer therapy [J].
Breier, A ;
Barancík, M ;
Sulová, Z ;
Uhrík, B .
CURRENT CANCER DRUG TARGETS, 2005, 5 (06) :457-468
[6]   Mechanism of inhibition of P-glycoprotein-mediated drug transport by protein kinase C blockers [J].
Castro, AF ;
Horton, JK ;
Vanoye, CG ;
Altenberg, GA .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (11) :1723-1733
[7]  
Chen B, 2004, WORLD J GASTROENTERO, V10, P795
[8]  
Davis JM, 2003, CLIN CANCER RES, V9, P1161
[9]   Cross-talk between signalling pathways and the multidrug resistant protein MDR-1 [J].
Ding, S ;
Chamberlain, M ;
McLaren, A ;
Goh, LB ;
Duncan, I ;
Wolf, CR .
BRITISH JOURNAL OF CANCER, 2001, 85 (08) :1175-1184
[10]   Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction [J].
Eneroth, A ;
Åström, E ;
Hoogstraate, J ;
Schrenk, D ;
Conrad, S ;
Kauffmann, HM ;
Gjellan, K .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 12 (03) :205-214